BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 25966064)

  • 1. Relationship between serum GAD-Ab and the genetic polymorphisms of GAD2 and type 2 diabetes mellitus.
    Li Q; Qiao ZR; Liu DB; Zeng JT; Zhang J; Bo Y; Zu HY; Hu Q; Wu X; Dong SS
    Genet Mol Res; 2015 Apr; 14(2):3002-9. PubMed ID: 25966064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical evaluation of non-insulin-dependent diabetes mellitus patients with autoantibodies to glutamic acid decarboxylase.
    Abiru N; Takino H; Yano M; Kawasaki E; Yamasaki H; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1996 Oct; 9(5):683-8. PubMed ID: 8933285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CTLA4 gene polymorphism contributes to the mode of onset of diabetes with antiglutamic acid decarboxylase antibody in Japanese patients: genetic analysis of diabetic patients with antiglutamic acid decarboxylase antibody.
    Abe T; Yamaguchi Y; Takino H; Fujita N; Yamauchi-Degawa M; Ozaki M; Yamakawa K; Sera Y; Sakamaki H; Uotani S; Kawasaki E; Awata T; Yamasaki H; Eguchi K
    Diabet Med; 2001 Sep; 18(9):726-31. PubMed ID: 11606170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroconversion of glutamic acid decarboxylase antibodies in a patient initially diagnosed as having type 2 diabetes mellitus.
    Nagai T; Imamura M; Mori M
    Intern Med; 2005 Apr; 44(4):299-302. PubMed ID: 15897639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of CTLA-4 polymorphism with positive anti-GAD antibody in Japanese subjects with type 1 diabetes mellitus.
    Hayashi H; Kusaka I; Nagasaka S; Kawakami A; Rokkaku K; Nakamura T; Saito T; Higashiyama M; Honda K; Ishikawa SE
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):793-9. PubMed ID: 10619986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Glutamic acid decarboxylase and tyrosine phosphatase-like IA-2 antibodies for diabetes classification in unselected diabetic patients].
    Reinsch B; Zimmy S; Schatz H; Pfohl M
    Med Klin (Munich); 2003 Feb; 98(2):67-71. PubMed ID: 12601530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity to CD38 and GAD in Type I and Type II diabetes: CD38 and HLA genotypes and clinical phenotypes.
    Antonelli A; Tuomi T; Nannipieri M; Fallahi P; Nesti C; Okamoto H; Groop L; Ferrannini E
    Diabetologia; 2002 Sep; 45(9):1298-306. PubMed ID: 12242463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5).
    Zampetti S; Spoletini M; Petrone A; Capizzi M; Arpi ML; Tiberti C; Di Pietro S; Bosi E; Pozzilli P; Giorgino F; Buzzetti R;
    Diabet Med; 2010 Jun; 27(6):701-4. PubMed ID: 20546291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of patients with the initial diagnosis of NIDDM with positivity for antibodies to glutamic acid decarboxylase.
    Inukai T; Fujiwara Y; Tayama K; Aso Y; Ogino K; Takemura Y
    Exp Clin Endocrinol Diabetes; 1997; 105(6):327-30. PubMed ID: 9439927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of glutamic acid decarboxylase autoantibody detection for early diagnosis of latent autoimmune diabetes in adults].
    Huang YY; Huang P; Lou HL
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):868-9. PubMed ID: 12919925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic markers for glutamic acid decarboxylase do not predict insulin-dependent diabetes mellitus in pairs of affected siblings. The Danish Study Group of Diabetes in Childhood.
    Rambrand T; Pociot F; Rønningen KS; Nerup J; Michelsen BK
    Hum Genet; 1997 Feb; 99(2):177-85. PubMed ID: 9048916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of polymorphisms in GAD1 and GAD2 genes with methamphetamine dependence.
    Veerasakul S; Watiktinkorn P; Thanoi S; Reynolds GP; Nudmamud-Thanoi S
    Pharmacogenomics; 2017 Jan; 18(1):17-22. PubMed ID: 27967329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relation between insulin resistance and glutamic acid decarboxylase antibody titers in latent autoimmune diabetes in adults].
    Li X; Huang G; Yan X; Yang L; Zhou ZG
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1247-9. PubMed ID: 20584648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of hydroxyl radical modified GAD65: a potential autoantigen in type 1 diabetes.
    Khan MW; Sherwani S; Khan WA; Ali R
    Autoimmunity; 2009 Feb; 42(2):150-8. PubMed ID: 19085183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the GAD65-GAD65 autoantibody interaction.
    Coco G; Chen S; Powell M; Brooking H; Zanchetta R; Betterle C; Smith BR; Furmaniak J
    Clin Chim Acta; 2008 May; 391(1-2):51-9. PubMed ID: 18328264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peculiar labeling of cultured hippocampal neurons by different sera harboring anti-glutamic acid decarboxylase autoantibodies (GAD-Ab).
    Vianello M; Giometto B; Vassanelli S; Canato M; Betterle C; Mucignat C
    Exp Neurol; 2006 Dec; 202(2):514-8. PubMed ID: 16890938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders.
    Unschuld PG; Ising M; Specht M; Erhardt A; Ripke S; Heck A; Kloiber S; Straub V; Brueckl T; Müller-Myhsok B; Holsboer F; Binder EB
    Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1100-9. PubMed ID: 19229853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.